Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
作者信息
SICUTERI F
出版信息
Med Exp Int J Exp Med. 1960;2:36-9. doi: 10.1159/000134839.
PMID:14446407
Abstract
摘要
相似文献
1
Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
Med Exp Int J Exp Med. 1960;2:36-9. doi: 10.1159/000134839.
2
Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
Arch Neurol. 1961 Mar;4:241-5. doi: 10.1001/archneur.1961.00450090007002.
3
[First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects].
Prog Med (Napoli). 1960 Jan 15;16:20-2.
4
Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.
Int Arch Allergy Appl Immunol. 1959;15:300-7. doi: 10.1159/000229055.
5
6
THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
Med Exp Int J Exp Med. 1964;10:137-43. doi: 10.1159/000135408.
7
The effect of a serotonin antagonist (UML 491) in carcinoid disease.
Lancet. 1961 Nov 25;2(7213):1172-4. doi: 10.1016/s0140-6736(61)90846-7.
8
Studies on headache. The responses of the bulbar conjunctival blood vessels during induced oliguria and diuresis, and their modification by UML-491.
Arch Neurol. 1961 Dec;5:590-3. doi: 10.1001/archneur.1961.00450180012003.
9
Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
Angiology. 1960 Aug;11:364-6. doi: 10.1177/000331976001100409.
10
ANTISEROTONIN ACTION OF LSD-25 AND OTHER LYSERGIC ACID DERIVATIVES: FACT AND FICTION.
J Asthma Res. 1964 Mar;1(3):207-11. doi: 10.3109/02770906409107675.
Zotero 插件